Form D — NewcelX Ltd.
0001213900-26-093018 · filed Aug 24, 2026
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Reported offering amount
- $2,940,234
- Reported amount sold
- $2,940,234
- Minimum investment
- $0
- Investors
- 5
- Sales commission
- $0
- Finders' fees
- $0
Issuer
- Name
- NewcelX Ltd.
- CIK
- 1783036
- Entity
- Other
- Jurisdiction
- SWITZERLAND
- Year incorporated
- —
- Address
- HOHSTRASSE 1
KLOTEN, V8 8302 - Phone
- 41 44 512 21 50
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Ronen Twito · Executive OfficerKloten, V8 Find on LinkedIn ↗
-
Michel Revel · Executive OfficerKloten, V8 Find on LinkedIn ↗
-
Kfir Molakandov · Executive OfficerKloten, V8 Find on LinkedIn ↗
-
Omri Hagai · Executive OfficerKloten, V8 Find on LinkedIn ↗
-
Alexander C. Zwyer · Executive OfficerKloten, V8 Find on LinkedIn ↗
-
Olivier Samuel · DirectorKloten, V8 Find on LinkedIn ↗
-
Eran Iohan · DirectorKloten, V8 Find on LinkedIn ↗
-
Liora Oren · DirectorKloten, V8 Find on LinkedIn ↗
-
Tamar Galili · DirectorKloten, V8 Find on LinkedIn ↗
Other filings from this issuer
View the original filing on SEC EDGAR ↗